Gopalakrishnan et al. showed that melanoma patients responding to anti-programmed cell death 1 protein (PD-1) immunotherapy had significantly higher alpha diversity (a measure of taxonomic diversity within communities) of the gut microbiota and Ruminococcaceae family abundance [5]. This evidence concerns the gene PDCD1 and melanoma.